Scleral crosslinking with riboflavin and ultraviolet A (UVA). A review

Crosslinking is a formation of chemical bonds between large molecules. It makes material stronger. Corneal crosslinking with riboflavin and ultraviolet A (UVA) has been successfully used in keratectasia treatment since 2003. There are some presuppositions of the scleral crosslinking successful using...

Full description

Bibliographic Details
Main Authors: M. M. Bikbov, V. K. Surkova, E. L. Usubov, M. N. Astrelin
Format: Article
Language:Russian
Published: Ophthalmology Publishing Group 2016-01-01
Series:Oftalʹmologiâ
Subjects:
Online Access:https://www.ophthalmojournal.com/opht/article/view/270
_version_ 1827063204974428160
author M. M. Bikbov
V. K. Surkova
E. L. Usubov
M. N. Astrelin
author_facet M. M. Bikbov
V. K. Surkova
E. L. Usubov
M. N. Astrelin
author_sort M. M. Bikbov
collection DOAJ
description Crosslinking is a formation of chemical bonds between large molecules. It makes material stronger. Corneal crosslinking with riboflavin and ultraviolet A (UVA) has been successfully used in keratectasia treatment since 2003. There are some presuppositions of the scleral crosslinking successful using in the progressive myopia, characterized by thinning and mechanical strength decrease of the sclera, as well as in corneal ectasia. Experimental investigations showed an increase in the mechanical strength of the sclera after crosslinking with riboflavin and UVA in vitro. At the same time there were no changes in the thickness of the sclera. Achieved biomechanical effect was constant over a time with interval during up to 8 months in rabbits in vivo. Scleral structure changes after crosslinking were studied with light, electron and atomic force microscopy. Dense collagen bundle at the same time with fibers diameter increase was observed. The spatial pattern of fibrils within crosslinked scleral tissue was tangled and running in different directions. Some authors found such side effects of the procedure as damage of the retina and cornea on the irradiation side because of the high irradiance and thinning of the sclera as a result of dehydration. The optimal duration of riboflavin instillation (20 minutes) and irradiation with 3 mW/cm² (40 minutes) were determined in the experiments. It was shown in vivo, that crosslinking of the sclera with riboflavin and UVA prevented the growth of the rabbit eyes in occlusion-induced myopia. There are several data about successful clinical using of the scleral crosslinking. However, only 6 patients (12 eyes) were observed, procedure parameters are not clear, follow-up period was only 6 months. Thus, now there are many unsolved questions about efficacy and safety of the scleral crosslinking with riboflavin and UVA. Experimental results encourage for a new method of the progressive myopia treatment will be created.
first_indexed 2024-04-10T01:49:08Z
format Article
id doaj.art-b60f292f4812413aab370cda97e7c2ca
institution Directory Open Access Journal
issn 1816-5095
2500-0845
language Russian
last_indexed 2025-02-18T20:10:08Z
publishDate 2016-01-01
publisher Ophthalmology Publishing Group
record_format Article
series Oftalʹmologiâ
spelling doaj.art-b60f292f4812413aab370cda97e7c2ca2024-10-17T16:11:55ZrusOphthalmology Publishing GroupOftalʹmologiâ1816-50952500-08452016-01-011244810.18008/1816-5095-2015-4-4-8260Scleral crosslinking with riboflavin and ultraviolet A (UVA). A reviewM. M. Bikbov0V. K. Surkova1E. L. Usubov2M. N. Astrelin3Ufa Eye Research InstituteUfa Eye Research InstituteUfa Eye Research InstituteUfa Eye Research InstituteCrosslinking is a formation of chemical bonds between large molecules. It makes material stronger. Corneal crosslinking with riboflavin and ultraviolet A (UVA) has been successfully used in keratectasia treatment since 2003. There are some presuppositions of the scleral crosslinking successful using in the progressive myopia, characterized by thinning and mechanical strength decrease of the sclera, as well as in corneal ectasia. Experimental investigations showed an increase in the mechanical strength of the sclera after crosslinking with riboflavin and UVA in vitro. At the same time there were no changes in the thickness of the sclera. Achieved biomechanical effect was constant over a time with interval during up to 8 months in rabbits in vivo. Scleral structure changes after crosslinking were studied with light, electron and atomic force microscopy. Dense collagen bundle at the same time with fibers diameter increase was observed. The spatial pattern of fibrils within crosslinked scleral tissue was tangled and running in different directions. Some authors found such side effects of the procedure as damage of the retina and cornea on the irradiation side because of the high irradiance and thinning of the sclera as a result of dehydration. The optimal duration of riboflavin instillation (20 minutes) and irradiation with 3 mW/cm² (40 minutes) were determined in the experiments. It was shown in vivo, that crosslinking of the sclera with riboflavin and UVA prevented the growth of the rabbit eyes in occlusion-induced myopia. There are several data about successful clinical using of the scleral crosslinking. However, only 6 patients (12 eyes) were observed, procedure parameters are not clear, follow-up period was only 6 months. Thus, now there are many unsolved questions about efficacy and safety of the scleral crosslinking with riboflavin and UVA. Experimental results encourage for a new method of the progressive myopia treatment will be created.https://www.ophthalmojournal.com/opht/article/view/270crosslinkingcross-linkingscleraprogressive myopiabiomechanical strengthultraviolet ariboflavincollagenocclusion-induced myopiarabbit modelyoung’s moduluslightelectronatomic forcemicroscopyretina damagecornea damagekeratoconuscollagen fiber diameter
spellingShingle M. M. Bikbov
V. K. Surkova
E. L. Usubov
M. N. Astrelin
Scleral crosslinking with riboflavin and ultraviolet A (UVA). A review
Oftalʹmologiâ
crosslinking
cross-linking
sclera
progressive myopia
biomechanical strength
ultraviolet a
riboflavin
collagen
occlusion-induced myopia
rabbit model
young’s modulus
light
electron
atomic force
microscopy
retina damage
cornea damage
keratoconus
collagen fiber diameter
title Scleral crosslinking with riboflavin and ultraviolet A (UVA). A review
title_full Scleral crosslinking with riboflavin and ultraviolet A (UVA). A review
title_fullStr Scleral crosslinking with riboflavin and ultraviolet A (UVA). A review
title_full_unstemmed Scleral crosslinking with riboflavin and ultraviolet A (UVA). A review
title_short Scleral crosslinking with riboflavin and ultraviolet A (UVA). A review
title_sort scleral crosslinking with riboflavin and ultraviolet a uva a review
topic crosslinking
cross-linking
sclera
progressive myopia
biomechanical strength
ultraviolet a
riboflavin
collagen
occlusion-induced myopia
rabbit model
young’s modulus
light
electron
atomic force
microscopy
retina damage
cornea damage
keratoconus
collagen fiber diameter
url https://www.ophthalmojournal.com/opht/article/view/270
work_keys_str_mv AT mmbikbov scleralcrosslinkingwithriboflavinandultravioletauvaareview
AT vksurkova scleralcrosslinkingwithriboflavinandultravioletauvaareview
AT elusubov scleralcrosslinkingwithriboflavinandultravioletauvaareview
AT mnastrelin scleralcrosslinkingwithriboflavinandultravioletauvaareview